Hollister - About the company
Hollister is an acquired company based in Spokane (United States), founded in 1949. It operates as an Injectable CDMO also offering allergenic extracts and immunotherapy products. The company has 390 active competitors, including 141 funded and 85 that have exited. Its top competitors include companies like Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics.
Company Details
Hollister-Stier Laboratories was acquired by Jubilant Organosys in April 2007 and since then has been known as Jubilant Hollister-Stier. Hollister-Stier was engaged in injectible contract manufacturing (Sterile and Non-sterile) and the allergy immunotherapy business. The erstwhile company had capabilities for development and manufacture of Vaccines, Biological Proteins, Microspheres, Liposomes, Suspensions, WFI/Diluents, and Lyophilized products. The company supported clients from Phase I to Commercialization development as well as manufacturing. It had specialised manufacturing capabilities for Lyophilization, Vial Filling, Aseptic Filling and Allergenic Extracts. Its facilities were approved by FDA, EMEA (Europe), PMDA (Japan) and ANVISA (Brazil).
- Website
- hollister-stier.com
Key Metrics
Founded Year
1949
Location
Spokane, United States
Stage
Acquired
Ranked
337th among 390 active competitors
Employee Count
18 as on May 31, 2026
Similar Companies
Exit Details
Acquired by Jubilant Life Sciences (Apr 24, 2007)
Legal entities associated with Hollister
Hollister is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Jubilant HollisterStier LLC CIN: 911956924 , United States, Active | - | 1197 (As on Dec 31, 2020) | - |
Hollister's acquisition details
Hollister got acquired by Jubilant Life Sciences on Apr 24, 2007 at an acquisition amount of $*****.
Click here to take a look at Hollister's acquisition in detail
Sign up to download Hollister's company profile
Hollister's funding and investors
Hollister is a funded company.
Hollister's founders and board of directors
Founder? Claim ProfileHollister's employee count trend
Hollister has 18 employees as of May 26. Here is Hollister's employee count trend over the years:
Uncover Hollister's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Hollister's Competitors and alternates
Top competitors of Hollister include Abcellera Biologics, Agios Pharmaceuticals and TScan Therapeutics. Here is the list of Top 10 competitors of Hollister, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcellera Biologics 2012, Vancouver (Canada), Public | AI-enabled platform for antibodies discovery | $115M | 76/100 | |
2nd | Agios Pharmaceuticals 2008, Cambridge (United States), Public | Developer of therapeutics in the field of cancer metabolism and rare genetic disorders of metabolism | $120M | 70/100 | |
3rd | _1556184640480.png?devicePixelRatio=2&height=30&width=30){kind=logo} TScan Therapeutics 1995, Boston (United States), Public | Developer of T cell therapies to harness the immune system against cancer | $180M | 70/100 | |
4th | ABL Bio 2016, Seongnam-si (South Korea), Public | Bi-specific antibodies and Antibody-drug Conjugate immunotherapies for oncology and neurodegenerative diseases | $65M | 67/100 | |
5th |  ImmunityBio 2014, El Segundo (United States), Public | Developer of peptide-based vaccines for immunotherapy | $169M | 67/100 | |
6th | _1548143983431.png?devicePixelRatio=2&height=30&width=30){kind=logo} Beijing Jiakesi drug development 2015, Beijing (China), Public | Developer of small molecule based therapeutics for cancer treatment | $55M | 66/100 | |
7th | _1568982092325.png?devicePixelRatio=2&height=30&width=30){kind=logo} Boundless Bio 2018, San Diego (United States), Public | Developer of therapeutics for cancer by targeting ecDNA | $252M | 65/100 | |
8th | Developer of vaccines against constantly mutating pathogens | $42.2M | 64/100 | ||
9th |  Brii Biosciences 2018, San Francisco (United States), Public | Developer of biologics to treat hepatitis B infection | $415M | 63/100 | |
10th | Lyell Immunopharma 2018, San Francisco (United States), Public | Developer of CAR- T therapy for cancer treatment | $493M | 63/100 | |
337th | Hollister 1949, Spokane (United States), Acquired | Injectable CDMO also offering allergenic extracts and immunotherapy products | - | - | 23/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Hollister's competitors? Click here to see the top ones
Hollister's Investments and acquisitions
Hollister has made no investments or acquisitions yet.
Reports related to Hollister
Here is the latest report on Hollister's geography:
Are you a Founder ?
FAQs about Hollister
Explore our recently published companies
- iBrandLabs - Hyderabad based, 2013 founded, Public company
- SmartIrrigate - Des Moines based, 2024 founded, Unfunded company
- Chrio - Hyderabad based, 2017 founded, Acquired company
- PreciAgro - Harare based, 2023 founded, Unfunded company
- Publishsutra - Hyderabad based, 2017 founded, Acquired company
- VerdiGen.ai - Dubai based, 2001 founded, Unfunded company
